These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22858844)

  • 1. 3-Phenylcoumarins as inhibitors of HIV-1 replication.
    Olmedo D; Sancho R; Bedoya LM; López-Pérez JL; Del Olmo E; Muñoz E; Alcamí J; Gupta MP; San Feliciano A
    Molecules; 2012 Aug; 17(8):9245-57. PubMed ID: 22858844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Phenylcoumarins as HIV transcription inhibitors.
    Bedoya LM; Beltrán M; Sancho R; Olmedo DA; Sánchez-Palomino S; del Olmo E; López-Pérez JL; Muñoz E; San Feliciano A; Alcamí J
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4447-50. PubMed ID: 16137881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
    J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways.
    Olmedo DA; López-Pérez JL; Del Olmo E; Bedoya LM; Sancho R; Alcamí J; Muñoz E; Feliciano AS; Gupta MP
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28218730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.
    Hamasaki T; Okamoto M; Baba M
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1323-31. PubMed ID: 23274668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT.
    Biswas DK; Mhashilkar AM; Ewaniuk DS; Pezza JA; Oh LM; Kannangara GS; Tius MA; Pardee AB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):426-34. PubMed ID: 9715838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.
    Kalantari P; Narayan V; Henderson AJ; Prabhu KS
    FASEB J; 2009 Aug; 23(8):2366-73. PubMed ID: 19299483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway.
    Lin PH; Ke YY; Su CT; Shiao HY; Hsieh HP; Chao YK; Lee CN; Kao CL; Chao YS; Chang SY
    J Virol; 2011 Sep; 85(17):9114-26. PubMed ID: 21697490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a dual reporter screening assay for distinguishing the inhibition of HIV Tat-mediated transcription from off-target effects.
    Shin Y; Choi BS; Kim KC; Kang C; Kim K; Yoon CH
    J Virol Methods; 2017 Nov; 249():1-9. PubMed ID: 28807730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.
    Wang X; Yamataka K; Okamoto M; Ikeda S; Baba M
    Antivir Chem Chemother; 2007; 18(4):201-11. PubMed ID: 17907378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel compounds against Tat-mediated human immunodeficiency virus-1 transcription by high-throughput functional screening assay.
    Shin Y; Kim HG; Park CM; Choi MS; Kim DE; Choi BS; Kim K; Yoon CH
    Biochem Biophys Res Commun; 2020 Mar; 523(2):368-374. PubMed ID: 31866007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication.
    Massari S; Daelemans D; Barreca ML; Knezevich A; Sabatini S; Cecchetti V; Marcello A; Pannecouque C; Tabarrini O
    J Med Chem; 2010 Jan; 53(2):641-8. PubMed ID: 19958026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway.
    Márquez N; Sancho R; Bedoya LM; Alcamí J; López-Pérez JL; Feliciano AS; Fiebich BL; Muñoz E
    Antiviral Res; 2005 Jun; 66(2-3):137-45. PubMed ID: 15911030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.
    Daelemans D; Esté JA; Witvrouw M; Pannecouque C; Jonckheere H; Aquaro S; Perno CF; De Clercq E; Vandamme AM
    Mol Pharmacol; 1997 Dec; 52(6):1157-63. PubMed ID: 9396786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride.
    Sato T; Asamitsu K; Yang JP; Takahashi N; Tetsuka T; Yoneyama A; Kanagawa A; Okamoto T
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):293-8. PubMed ID: 9519889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
    Kelly GD; Morris CB; Offermann MK
    Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.
    Victoriano AF; Asamitsu K; Hibi Y; Imai K; Barzaga NG; Okamoto T
    Antimicrob Agents Chemother; 2006 Feb; 50(2):547-55. PubMed ID: 16436709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canventol inhibits HIV-1 replication by Tat-induced Tar-independent mechanism.
    Biswas DK; Tius MA; Zhuo J; Pardee AB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):120-7. PubMed ID: 8680882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.